Literature DB >> 28066573

Low dose dexmedetomidine for the prophylaxis of perioperative ICU delirium-how much evidence is enough?

Michael C Reade1.   

Abstract

Entities:  

Year:  2016        PMID： 28066573      PMCID： PMC5179429          DOI： 10.21037/jtd.2016.11.30

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  23 in total

1.  Postoperative delirium in older adults: best practice statement from the American Geriatrics Society.

Authors: 
Journal:  J Am Coll Surg       Date:  2014-11-14       Impact factor: 6.113

2.  Preventing postoperative delirium: all that glisters is not gold.

Authors:  Vanessa L Kronzer; Michael S Avidan
Journal:  Lancet       Date:  2016-08-16       Impact factor: 79.321

3.  Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole.

Authors:  W E Hoffman; E Kochs; C Werner; C Thomas; R F Albrecht
Journal:  Anesthesiology       Date:  1991-08       Impact factor: 7.892

4.  Drotrecogin alfa (activated) in adults with septic shock.

Authors:  V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Simon Finfer; Bengt Gårdlund; John C Marshall; Andrew Rhodes; Antonio Artigas; Didier Payen; Jyrki Tenhunen; Hussein R Al-Khalidi; Vivian Thompson; Jonathan Janes; William L Macias; Burkhard Vangerow; Mark D Williams
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

5.  Detection of delirium in the intensive care unit: comparison of confusion assessment method for the intensive care unit with confusion assessment method ratings.

Authors:  Lynn McNicoll; Margaret A Pisani; E Wesley Ely; David Gifford; Sharon K Inouye
Journal:  J Am Geriatr Soc       Date:  2005-03       Impact factor: 5.562

6.  Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.

Authors:  Richard R Riker; Yahya Shehabi; Paula M Bokesch; Daniel Ceraso; Wayne Wisemandle; Firas Koura; Patrick Whitten; Benjamin D Margolis; Daniel W Byrne; E Wesley Ely; Marcelo G Rocha
Journal:  JAMA       Date:  2009-02-02       Impact factor: 56.272

7.  Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Brenda T Pun; Daniel L Herr; Mervyn Maze; Timothy D Girard; Russell R Miller; Ayumi K Shintani; Jennifer L Thompson; James C Jackson; Stephen A Deppen; Renee A Stiles; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  JAMA       Date:  2007-12-12       Impact factor: 56.272

8.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

Review 9.  A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.

Authors:  D C Angus; A E Barnato; D Bell; R Bellomo; C-R Chong; T J Coats; A Davies; A Delaney; D A Harrison; A Holdgate; B Howe; D T Huang; T Iwashyna; J A Kellum; S L Peake; F Pike; M C Reade; K M Rowan; M Singer; S A R Webb; L A Weissfeld; D M Yealy; J D Young
Journal:  Intensive Care Med       Date:  2015-05-08       Impact factor: 17.440

10.  Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.

Authors:  Marc Schoeler; Philip D Loetscher; Rolf Rossaint; Astrid V Fahlenkamp; Georg Eberhardt; Steffen Rex; Joachim Weis; Mark Coburn
Journal:  BMC Neurol       Date:  2012-04-11       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.